The iPSC-derived neuron rapid-antidepressant study will report time-dependent plasticity differences between TRD and healthy donors in a peer-reviewed journal before 2026-09-30.

Predicted 2026-07-25 · Resolves 2026-09-30 · research · Global

55%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

Scientists are using a technique that turns human skin or blood cells into working brain cells in a dish — called iPSC (induced pluripotent stem cell)-derived neurons — to study why some people's depression doesn't respond to normal treatments. A study comparing brain cells from people with treatment-resistant depression (TRD) to cells from healthy people is expected to show that the two groups respond differently to fast-acting antidepressants as time passes. This matters because it could explain why some people don't get better and point toward more personalized treatments.

Resolution rule: YES if, by 2026-09-30, a peer-reviewed paper (or preprint on bioRxiv/medRxiv) indexed on pubmed.ncbi.nlm.nih.gov or the preprint server reports time-dependent synaptic plasticity differences between iPSC-derived neurons from treatment-resistant-depression and healthy donors in the context of rapid-acting antidepressants. Checked 2026-09-30. NO otherwise.

The underlying signal names the exact comparison (TRD vs healthy iPSC donors, time-dependent plasticity). Publishable mechanistic data differentiating rapid-acting antidepressant response. Falsifiable against the published-record.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →